Parvo Shield L5E

Company: Elanco (Farm Animal)

Parvovirus Vaccine

Killed Virus

Erysipelothrix Rhusiopathiae-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For Use In Animals Only

Gilt

Sow

Parvo Shield L5E Indications

This product has been shown to be effective for the vaccination of healthy swine against disease caused by porcine parvovirus, Erysipelothrix rhusiopathiae, and Leptospira canicola, grippotyphosa, hardjo, icterohaemorrhagiae, and pomona. This product was licensed prior the requirement to establish a minimum age for use. The duration of immunity for this product has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Adjuvant: Aluminum hydroxide.

Directions For Use

Shake well before using. Administer 5 mL intramuscularly to gilts and sows 4 to 6 weeks prior to breeding. Repeat in 3 to 4 weeks. Revaccinate with a single dose 4 to 6 weeks prior to each subsequent breeding. Vaccinate boars semiannually.

Precautions

Store out of direct sunlight at 2 to 8° C (35 to 46° F). DO NOT FREEZE. Do not mix with other products except as specified on the label. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. This product has not been tested in pregnant animals. In case of human exposure, contact a physician. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

VLN/PCN: 196/48C5.20

Elanco US Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441

Parvo Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

CPN: 1114028.10